CBUS
Cibus, Inc.
Price Chart
Latest Quote
$1.36
| Previous Close | $1.29 |
| Open | $1.33 |
| Day High | $1.41 |
| Day Low | $1.28 |
| Volume | 780,540 |
Stock Information
| Shares Outstanding | 76.33M |
| Total Debt | $267.96M |
| Cash Equivalents | $9.92M |
| Revenue | $3.64M |
| Net Income | $-127.08M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $110.13M |
| EPS (TTM) | $-1.77 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $348.69M |
| Sales | $3.64M |
| Income | $-127.08M |
| Book/sh | $0.40 |
| Cash/sh | $0.13 |
| Employees | 118 |
Financial Ratios
| Quick Ratio | 0.63 |
| Current Ratio | 0.72 |
| Debt/Eq | 1227.56 |
Returns & Margins
| ROA | -12.87% |
| ROE | -220.96% |
| Gross Margin | 100.00% |
| Operating Margin | -1273.32% |
Ownership
| Insider Ownership | 26.13% |
| Institutional Ownership | 33.60% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -2.16 |
| P/S | 30.26 |
| P/B | 3.38 |
Analyst Data
| Recommendation | buy |
| Target Price | $14.67 |
Technical Indicators
| SMA20 | $1.34 |
| SMA50 | $1.40 |
| SMA200 | $1.79 |
| RSI | 42.86 |
| ATR | 0.1033 |
| Shares Float | 51.84M |
| Short Float | 8.44% |
| Short Ratio | 15.61 |
| Volatility | 1.65 |
| Rel Volume | 2.80 |
Performance History
| Week | +8.80% |
| Month | +4.62% |
| Quarter | -48.87% |
| 6 Months | -12.82% |
| YTD | -27.66% |
| Year | -6.21% |
| 3 Years | -91.71% |
| 5 Years | -99.42% |
| 10 Years | -99.76% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.36 | 808,200 |
| 2026-06-17 | $1.29 | 246,900 |
| 2026-06-16 | $1.31 | 115,000 |
| 2026-06-15 | $1.27 | 342,300 |
| 2026-06-12 | $1.23 | 297,000 |
| 2026-06-11 | $1.25 | 228,600 |
| 2026-06-10 | $1.20 | 277,500 |
| 2026-06-09 | $1.23 | 263,400 |
| 2026-06-08 | $1.23 | 228,000 |
| 2026-06-05 | $1.29 | 448,900 |
| 2026-06-04 | $1.40 | 127,300 |
| 2026-06-03 | $1.39 | 183,300 |
| 2026-06-02 | $1.39 | 323,600 |
| 2026-06-01 | $1.47 | 275,700 |
| 2026-05-29 | $1.44 | 216,300 |
| 2026-05-28 | $1.45 | 325,200 |
| 2026-05-27 | $1.50 | 329,800 |
| 2026-05-26 | $1.43 | 294,300 |
| 2026-05-22 | $1.38 | 285,400 |
| 2026-05-21 | $1.38 | 146,500 |
| 2026-05-20 | $1.42 | 296,300 |
| 2026-05-19 | $1.30 | 452,400 |
About Cibus, Inc.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
đ° Latest News
Cibus, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-15T12:30:00ZCibus Inc (CBUS) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
GuruFocus.com âĸ 2026-05-15T05:02:27ZCibus Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-14T22:10:35ZCibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-14T21:50:02ZBioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates
Zacks âĸ 2026-05-12T00:05:03ZCibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?
Zacks âĸ 2026-05-06T16:00:04ZCibus, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-19T00:14:48ZCibus Q4 Earnings Call Highlights
MarketBeat âĸ 2026-03-18T19:33:15ZCibus Inc (CBUS) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
GuruFocus.com âĸ 2026-03-18T03:01:35ZCibus (CBUS) Q4 2025 Earnings Call Transcript
Motley Fool âĸ 2026-03-17T23:05:15ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $3,639,000 | $4,262,000 | $1,817,000 | $157,000 |
| Operating Revenue | $3,639,000 | $4,262,000 | $1,817,000 | $157,000 |
| Reconciled Cost Of Revenue | - | - | - | $0 |
| Cost Of Revenue | - | - | - | $0 |
| Expenses | ||||
| Interest Expense | $35,481,000 | $34,190,000 | $18,892,000 | $87,000 |
| Total Expenses | $71,103,000 | $81,226,000 | $71,281,000 | $22,527,000 |
| Other Income Expense | $-29,665,000 | $-172,161,000 | $-249,814,000 | $5,566,000 |
| Other Non Operating Income Expenses | $400,000 | $9,271,000 | $-395,000 | $5,566,000 |
| Net Non Operating Interest Income Expense | $-35,043,000 | $-33,559,000 | $-18,365,000 | $-87,000 |
| Interest Expense Non Operating | $35,481,000 | $34,190,000 | $18,892,000 | $87,000 |
| Operating Expense | $71,103,000 | $81,226,000 | $71,281,000 | $22,527,000 |
| Total Other Finance Cost | - | - | - | $72,000 |
| Other Operating Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-127,085,000 | $-251,388,000 | $-267,627,000 | $-16,891,000 |
| Net Interest Income | $-35,043,000 | $-33,559,000 | $-18,365,000 | $-87,000 |
| Interest Income | $438,000 | $631,000 | $527,000 | $60,000 |
| Normalized Income | $-97,020,000 | $-69,956,000 | $-18,210,955 | $-16,891,000 |
| Net Income From Continuing And Discontinued Operation | $-127,085,000 | $-251,388,000 | $-267,627,000 | $-16,891,000 |
| Total Operating Income As Reported | $-97,529,000 | $-258,396,000 | $-318,883,000 | $-22,370,000 |
| Net Income Common Stockholders | $-127,085,000 | $-251,388,000 | $-267,627,000 | $-16,891,000 |
| Net Income | $-127,085,000 | $-251,388,000 | $-267,627,000 | $-16,891,000 |
| Net Income Including Noncontrolling Interests | $-132,201,000 | $-282,713,000 | $-337,639,000 | $-16,891,000 |
| Net Income Continuous Operations | $-132,201,000 | $-282,713,000 | $-337,639,000 | $-16,891,000 |
| Pretax Income | $-132,172,000 | $-282,684,000 | $-337,643,000 | $-16,891,000 |
| Special Income Charges | $-30,065,000 | $-181,432,000 | $-249,419,000 | $0 |
| Interest Income Non Operating | $438,000 | $631,000 | $527,000 | $60,000 |
| Operating Income | $-67,464,000 | $-76,964,000 | $-69,464,000 | $-22,370,000 |
| Gross Profit | $3,639,000 | $4,262,000 | $1,817,000 | $157,000 |
| Per Share | ||||
| Diluted EPS | $-2.78 | $-10.83 | $-25.95 | $-18.50 |
| Basic EPS | $-2.78 | $-10.83 | $-25.95 | $-18.50 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $-2,955 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-60,703,000 | $-60,203,000 | $-64,639,000 | $-15,270,000 |
| Total Unusual Items | $-30,065,000 | $-181,432,000 | $-249,419,000 | $0 |
| Total Unusual Items Excluding Goodwill | $-30,065,000 | $-181,432,000 | $-249,419,000 | $0 |
| Reconciled Depreciation | $5,923,000 | $6,859,000 | $4,693,000 | $1,534,000 |
| EBITDA (Bullshit earnings) | $-90,768,000 | $-241,635,000 | $-314,058,000 | $-15,270,000 |
| EBIT | $-96,691,000 | $-248,494,000 | $-318,751,000 | $-16,804,000 |
| Diluted Average Shares | $45,757,376 | $23,222,256 | $10,314,554 | $919,950 |
| Basic Average Shares | $45,757,376 | $23,222,256 | $10,314,554 | $919,950 |
| Diluted NI Availto Com Stockholders | $-127,085,000 | $-251,388,000 | $-267,627,000 | $-16,891,000 |
| Minority Interests | $5,116,000 | $31,325,000 | $70,012,000 | $0 |
| Tax Provision | $29,000 | $29,000 | $-4,000 | $0 |
| Impairment Of Capital Assets | $30,065,000 | $181,432,000 | $249,419,000 | $0 |
| Research And Development | $44,198,000 | $50,429,000 | $42,367,000 | $11,553,000 |
| Selling General And Administration | $26,905,000 | $30,797,000 | $28,914,000 | $10,974,000 |
| Restructuring And Mergern Acquisition | - | - | - | $0 |
| Other Special Charges | - | - | - | - |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-242,366,000 | $-194,887,000 | $-176,839,000 | $7,075,000 |
| Total Assets | $305,047,000 | $350,069,000 | $544,411,000 | $22,421,000 |
| Total Non Current Assets | $292,978,000 | $333,123,000 | $509,191,000 | $18,289,000 |
| Other Non Current Assets | $926,000 | $1,386,000 | $1,422,000 | $158,000 |
| Goodwill And Other Intangible Assets | $264,195,000 | $287,044,000 | $470,309,000 | $158,000 |
| Other Intangible Assets | $31,679,000 | $33,578,000 | $35,411,000 | $158,000 |
| Current Assets | $12,069,000 | $16,946,000 | $35,220,000 | $4,132,000 |
| Other Current Assets | $1,643,000 | $1,472,000 | $1,991,000 | $606,000 |
| Receivables | $503,000 | $1,041,000 | $530,000 | $0 |
| Accounts Receivable | $503,000 | $1,041,000 | $530,000 | $0 |
| Allowance For Doubtful Accounts Receivable | $0 | $0 | $0 | $0 |
| Gross Accounts Receivable | $503,000 | $1,041,000 | $530,000 | $0 |
| Cash Cash Equivalents And Short Term Investments | $9,923,000 | $14,433,000 | $32,699,000 | $3,427,000 |
| Cash And Cash Equivalents | $9,923,000 | $14,433,000 | $32,699,000 | $3,427,000 |
| Restricted Cash | - | - | $0 | $99,000 |
| Prepaid Assets | - | - | - | - |
| Inventory | - | - | - | - |
| Debt | ||||
| Total Debt | $33,042,000 | $36,286,000 | $24,621,000 | $13,911,000 |
| Long Term Debt And Capital Lease Obligation | $29,876,000 | $31,450,000 | $17,674,000 | $13,447,000 |
| Long Term Debt | $93,000 | $226,000 | $536,000 | - |
| Current Debt And Capital Lease Obligation | $3,166,000 | $4,836,000 | $6,947,000 | $464,000 |
| Current Debt | $435,000 | $436,000 | $833,000 | - |
| Other Current Borrowings | $435,000 | $436,000 | $833,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $283,218,000 | $252,238,000 | $206,117,000 | $15,188,000 |
| Total Non Current Liabilities Net Minority Interest | $266,360,000 | $232,360,000 | $184,794,000 | $13,526,000 |
| Other Non Current Liabilities | $1,561,000 | $1,468,000 | $1,868,000 | $79,000 |
| Tradeand Other Payables Non Current | $0 | $0 | $0 | $0 |
| Current Liabilities | $16,858,000 | $19,878,000 | $21,323,000 | $1,662,000 |
| Other Current Liabilities | $79,000 | $2,556,000 | $1,434,000 | $296,000 |
| Current Deferred Liabilities | $536,000 | $932,000 | $1,210,000 | $107,000 |
| Payables And Accrued Expenses | $10,016,000 | $8,245,000 | $7,874,000 | $688,000 |
| Payables | $8,070,000 | $5,964,000 | $6,127,000 | $515,000 |
| Accounts Payable | $8,070,000 | $5,964,000 | $6,127,000 | $340,000 |
| Equity | ||||
| Common Stock Equity | $21,829,000 | $92,157,000 | $293,470,000 | $7,233,000 |
| Total Equity Gross Minority Interest | $21,829,000 | $97,831,000 | $338,294,000 | $7,233,000 |
| Stockholders Equity | $21,829,000 | $92,157,000 | $293,470,000 | $7,233,000 |
| Gains Losses Not Affecting Retained Earnings | $39,000 | $15,000 | $8,000 | $0 |
| Other Equity Adjustments | $39,000 | $15,000 | $8,000 | - |
| Retained Earnings | $-858,251,000 | $-731,166,000 | $-479,778,000 | $-212,151,000 |
| Other | ||||
| Treasury Shares Number | $193,195 | $45,177 | $32,663 | $2,003 |
| Ordinary Shares Number | $54,325,852 | $27,939,023 | $20,567,656 | $976,892 |
| Share Issued | $54,519,047 | $27,984,200 | $20,600,319 | $978,895 |
| Tangible Book Value | $-242,366,000 | $-194,887,000 | $-176,839,000 | $7,075,000 |
| Invested Capital | $22,357,000 | $92,819,000 | $294,839,000 | $7,233,000 |
| Working Capital | $-4,789,000 | $-2,932,000 | $13,897,000 | $2,470,000 |
| Capital Lease Obligations | $32,514,000 | $35,624,000 | $23,252,000 | $13,911,000 |
| Total Capitalization | $21,922,000 | $92,383,000 | $294,006,000 | $7,233,000 |
| Minority Interest | $0 | $5,674,000 | $44,824,000 | $0 |
| Treasury Stock | $2,141,000 | $1,999,000 | $1,785,000 | $1,043,000 |
| Additional Paid In Capital | $882,171,000 | $825,298,000 | $775,017,000 | $220,422,000 |
| Capital Stock | $11,000 | $9,000 | $8,000 | $5,000 |
| Common Stock | $11,000 | $9,000 | $8,000 | $5,000 |
| Dueto Related Parties Non Current | $234,923,000 | $199,442,000 | $165,252,000 | $0 |
| Long Term Capital Lease Obligation | $29,783,000 | $31,224,000 | $17,138,000 | $13,447,000 |
| Current Deferred Revenue | $536,000 | $932,000 | $1,210,000 | $107,000 |
| Current Capital Lease Obligation | $2,731,000 | $4,400,000 | $6,114,000 | $464,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $3,061,000 | $3,309,000 | $3,858,000 | $107,000 |
| Current Accrued Expenses | $1,946,000 | $2,281,000 | $1,747,000 | $173,000 |
| Goodwill | $232,516,000 | $253,466,000 | $434,898,000 | $0 |
| Net PPE | $27,857,000 | $44,693,000 | $37,460,000 | $18,131,000 |
| Accumulated Depreciation | $-17,041,000 | $-13,517,000 | $-8,977,000 | $-5,877,000 |
| Gross PPE | $44,898,000 | $58,210,000 | $46,437,000 | $24,008,000 |
| Leases | $2,458,000 | $4,256,000 | $3,912,000 | $364,000 |
| Construction In Progress | $155,000 | $216,000 | $704,000 | $0 |
| Other Properties | $21,557,000 | $33,254,000 | $21,685,000 | $13,615,000 |
| Machinery Furniture Equipment | $19,828,000 | $19,584,000 | $19,236,000 | $9,129,000 |
| Buildings And Improvements | $900,000 | $900,000 | $900,000 | $900,000 |
| Properties | $0 | $0 | $0 | $0 |
| Dueto Related Parties Current | - | - | $0 | $175,000 |
| Land And Improvements | - | - | - | $0 |
| Raw Materials | - | - | - | - |
| Other Short Term Investments | - | - | - | - |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-51,169,000 | $-58,851,000 | $-50,531,000 | $-20,884,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-50,591,000 | $-58,043,000 | $-46,210,000 | $-19,364,000 |
| Cash Flow From Continuing Operating Activities | $-50,591,000 | $-58,043,000 | $-46,210,000 | $-19,364,000 |
| Operating Gains Losses | $-406,000 | $-8,966,000 | $1,351,000 | $-5,120,000 |
| Investing Activities | ||||
| Capital Expenditure | $-578,000 | $-808,000 | $-4,321,000 | $-1,520,000 |
| Investing Cash Flow | $-578,000 | $-808,000 | $55,060,000 | $-1,520,000 |
| Cash Flow From Continuing Investing Activities | $-578,000 | $-808,000 | $55,060,000 | $-1,520,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $50,100,000 | $43,902,000 | $20,306,000 | $11,538,000 |
| Financing Cash Flow | $46,648,000 | $40,598,000 | $20,320,000 | $9,989,000 |
| Cash Flow From Continuing Financing Activities | $46,648,000 | $40,598,000 | $20,320,000 | $9,989,000 |
| Net Other Financing Charges | $-2,344,000 | $-2,425,000 | $-2,292,000 | $-1,173,000 |
| Net Common Stock Issuance | $50,100,000 | $43,902,000 | $20,306,000 | $11,538,000 |
| Common Stock Issuance | $50,100,000 | $43,902,000 | $20,306,000 | $11,538,000 |
| Other | ||||
| Repayment Of Debt | $-1,108,000 | $-1,083,000 | $-1,572,000 | $-376,000 |
| Issuance Of Debt | $0 | $204,000 | $3,878,000 | $0 |
| End Cash Position | $9,923,000 | $14,433,000 | $32,699,000 | $3,526,000 |
| Beginning Cash Position | $14,433,000 | $32,699,000 | $3,526,000 | $14,421,000 |
| Effect Of Exchange Rate Changes | $11,000 | $-13,000 | $3,000 | $0 |
| Changes In Cash | $-4,521,000 | $-18,253,000 | $29,170,000 | $-10,895,000 |
| Net Issuance Payments Of Debt | $-1,108,000 | $-879,000 | $2,306,000 | $-376,000 |
| Net Long Term Debt Issuance | $-1,108,000 | $-879,000 | $2,306,000 | $-376,000 |
| Long Term Debt Payments | $-1,108,000 | $-1,083,000 | $-1,572,000 | $-376,000 |
| Long Term Debt Issuance | $0 | $204,000 | $3,878,000 | $0 |
| Net PPE Purchase And Sale | $-578,000 | $-808,000 | $-4,321,000 | $-1,520,000 |
| Purchase Of PPE | $-578,000 | $-808,000 | $-4,321,000 | $-1,520,000 |
| Change In Working Capital | $2,321,000 | $383,000 | $961,000 | $-2,885,000 |
| Change In Other Working Capital | $715,000 | $492,000 | $-721,000 | $-464,000 |
| Change In Payables And Accrued Expense | $85,000 | $-115,000 | $-1,172,000 | $-2,810,000 |
| Change In Accrued Expense | $-635,000 | $73,000 | $-1,174,000 | $-2,581,000 |
| Change In Payable | $720,000 | $-188,000 | $2,000 | $-229,000 |
| Change In Account Payable | $720,000 | $-188,000 | $2,000 | $-229,000 |
| Change In Prepaid Assets | $983,000 | $518,000 | $1,150,000 | $389,000 |
| Change In Receivables | $538,000 | $-512,000 | $1,704,000 | $0 |
| Changes In Account Receivables | $538,000 | $-512,000 | $1,704,000 | $0 |
| Other Non Cash Items | $35,519,000 | $34,212,000 | $18,913,000 | - |
| Stock Based Compensation | $8,188,000 | $10,750,000 | $16,092,000 | $3,998,000 |
| Asset Impairment Charge | $30,065,000 | $181,432,000 | $249,419,000 | $0 |
| Depreciation Amortization Depletion | $5,923,000 | $6,859,000 | $4,693,000 | $1,534,000 |
| Depreciation And Amortization | $5,923,000 | $6,859,000 | $4,693,000 | $1,534,000 |
| Gain Loss On Investment Securities | $-447,000 | $-9,301,000 | $1,127,000 | $-5,120,000 |
| Gain Loss On Sale Of PPE | $41,000 | $335,000 | $224,000 | $0 |
| Net Income From Continuing Operations | $-132,201,000 | $-282,713,000 | $-337,639,000 | $-16,891,000 |
| Net Business Purchase And Sale | - | $0 | $59,381,000 | $0 |
| Sale Of Business | - | $0 | $59,381,000 | $0 |
| Interest Paid Supplemental Data | - | - | $123,000 | $69,000 |
| Net Short Term Debt Issuance | - | - | $3,878,000 | $0 |
| Short Term Debt Payments | - | - | $-1,275,000 | $0 |
| Short Term Debt Issuance | - | - | $3,878,000 | $0 |
| Amortization Cash Flow | - | - | $1,125,000 | - |
| Amortization Of Intangibles | - | - | $1,125,000 | - |
| Depreciation | - | - | $3,568,000 | - |
| Proceeds From Stock Option Exercised | - | - | - | $0 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Change In Inventory | - | - | - | $0 |